Boksan Nice attracts KRW 52 billion investment from Japanese Suzuken
A domestic pharmaceutical distribution company succeeded in attracting a large-scale investment once again.
Boksan Nice Pharm(President Tae-eung Um) announced it has concluded a business and capital agreement with Suzuken, a Japanese large company, on June 17 to contribute to the pharmaceutical ...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
